SCHEMBL50622

SCHEMBL50622

Cc1ccc(O)c(Cc2cc(C)ccc2O)c1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AMY1A P0DUB6 1/20 0.83
TRPA1 O75762 2/20 0.56
TP53 P04637 2/20 0.54
TDP1 Q9NUW8 1/20 0.54
ALOX15 P16050 4/20 0.54
LMNA P02545 4/20 0.54
HPGD P15428 3/20 0.54
MAPT P10636 3/20 0.54
HSPA5 P11021 3/20 0.54
HTT P42858 2/20 0.54
MEN1 O00255 2/20 0.54
ALOX12 P18054 2/20 0.54
KMT2A Q03164 2/20 0.54
HIF1A Q16665 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
SLC22A1 O15245 1/20 0.54
USP2 O75604 1/20 0.54
HSP90AA1 P07900 1/20 0.54
CYP3A4 P08684 1/20 0.54
HSPD1 P10809 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29402131 1.00 AMY1A (0.83) AMY1ATRPA1TP53TDP1ALOX15
SCHEMBL29621432 1.00 AMY1A (0.83) AMY1ATRPA1TP53TDP1ALOX15
Methyl Alcohol SCHEMBL3081581 0.98 AMY1A (0.80) AMY1ATRPA1TP53TDP1ALOX15
SCHEMBL3820165 0.91 AMY1A (1.00) AMY1ATRPA1TP53TDP1ALOX15
SCHEMBL22664017 0.91 AMY1A (0.78) AMY1ATRPA1TP53TDP1ALOX15
SCHEMBL1345514 0.91 AMY1A (1.00) AMY1ATRPA1TP53TDP1ALOX15
SCHEMBL30320292 0.91 AMY1A (1.00) AMY1ATRPA1TP53TDP1ALOX15
SCHEMBL18352 0.91 AMY1A (1.00) AMY1ATRPA1TP53TDP1ALOX15
SCHEMBL1345563 0.91 AMY1A (1.00) AMY1ATRPA1TP53TDP1ALOX15
SCHEMBL1345917 0.91 AMY1A (1.00) AMY1ATRPA1TP53TDP1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1225 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12275695-B2 Fluid catalytic cracking of p-cresol dimer into phenolic monomers and process thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2025-04-15 US claimed
US-20230202953-A1 FLUID CATALYTIC CRACKING OF P-CRESOL DIMER INTO PHENOLIC MONOMERS AND PROCESS THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2023-06-29 US claimed
EP-3717532-B1 BIOGENIC OLIGOMERS AS REACTIVE SUPPLEMENTS FOR CURING OF REACTIVE RESINS HILTI AG (LI) 2023-05-10 EP claimed
CN-115703871-A Phenolic resin and preparation method and application thereof 合肥鼎材科技有限公司 2023-02-17 CN claimed
CN-114555674-A Photosensitive composition and application thereof 普罗米鲁斯有限责任公司 2022-05-27 CN claimed
US-10934378-B2 Biogenic oligomers as reactive additives for the curing of reactive resins HILTI AKTIENGESELLSCHAFT (LI) 2021-03-02 US claimed
US-20200354494-A1 Biogenic oligomers as reactive additives for the curing of reactive resins HILTI AKTIENGESELLSCHAFT (LI) 2020-11-12 US claimed
EP-3717532-A1 BIOGENIC OLIOGOMERS AS REACTIVE ADDITIVES FOR THE CURING OF REACTIVE RESINS Hilti Aktiengesellschaft (LI) 2020-10-07 EP claimed
EP-3489267-A1 BIOGENIC OLIGOMERS AS REACTIVE SUPPLEMENTS FOR CURING OF REACTIVE RESINS HILTI Aktiengesellschaft (LI) 2019-05-29 EP claimed
US-7671167-B2 Poly(arylene ether) copolymer SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-03-02 US claimed
US-6379862-B1 PHENOLIC RESINS COMPRISING METHYLOLATED BISPHENOLS CONDENSED WITH PHENOLS; ALKALI-SOLUBLE RESIN, ACID GENERATOR, AND CROSSLINKING AGENT; HEAT RESISTANCE; LIQUID CRYSTAL DISPLAYS; SEMICONDUCTORS CLARIANT FINANCE (BVI) LIMITED (VG) 2002-04-30 US claimed
EP-0490966-B1 RADIATION-SENSITIVE COMPOSITIONS CONTAINING FULLY SUBSTITUTED NOVOLAK POLYMERS OLIN MICROELECTRONIC CHEM INC (US) 1998-11-04 EP claimed
EP-0591984-B1 Resin composition for aqueous paint KANSAI PAINT CO LTD (JP) 1997-07-09 EP claimed
US-5407748-A Resin composition for aqueous paint KANSAI PAINT CO., LTD. (JP) 1995-04-18 US claimed
EP-0633501-A2 Photosensitive material and image forming method CANON KABUSHIKI KAISHA (JP) 1995-01-11 EP claimed
US-5324620-A Radiation-sensitive compositions containing novolak polymers made from four phenolic derivatives and an aldehyde OCG MICROELETRONIC MATERIALS, INC. (US) 1994-06-28 US claimed
EP-0591984-A1 Resin composition for aqueous paint KANSAI PAINT CO., LTD. (JP) 1994-04-13 EP claimed
EP-0490966-A4 RADIATION-SENSITIVE COMPOSITIONS CONTAINING FULLY SUBSTITUTED NOVOLAK POLYMERS 1992-10-21 EP claimed
EP-0490966-A1 RADIATION-SENSITIVE COMPOSITIONS CONTAINING FULLY SUBSTITUTED NOVOLAK POLYMERS OCG MICROELECTRONICS MATERIALS, INC. (US) 1992-06-24 EP claimed
WO-1991003769-A1 RADIATION-SENSITIVE COMPOSITIONS CONTAINING FULLY SUBSTITUTED NOVOLAK POLYMERS OLIN HUNT SPECIALTY PRODUCTS INC. (US) 1991-03-21 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230202953-A1 FLUID CATALYTIC CRACKING OF P-CRESOL DIMER INTO PHENOLIC MONOMERS AND PROCESS THEREOF CAT, MCCC2, FOS AMY1A 1588/4885TRPA1 2424/4885TP53 1905/4885
US-12275695-B2 Fluid catalytic cracking of p-cresol dimer into phenolic monomers and process thereof CAT, MCCC2, FOS AMY1A 1588/4885TRPA1 2424/4885TP53 1905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.